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Resume
Objective: Posterior urethral valves (PUV) diagnosis and management remain a major challenge in 
developing countries. We sought to review cases of PUV managed in our health centre and to highlight the 
challenges in its management.
Methods: A retrospective analysis of patients with PUV managed over a 12month period. Data obtained 
from patients' medical records include: demography, clinical presentation, serum electrolytes, urea and 
creatinine, radiological diagnosis, initial management, surgical management and the outcome of 
management.
Results: Eight patients were managed during the period under review. The median age was 26 months. 
The commonest clinical feature was recurrent fever. Three patients (37.5%) had renal insufficiency 
requiring peritoneal dialysis at initial presentation. Six patients (75%) had Mohan's valvotomy while two 
(25%) died before valve ablation. One patient (12.5%) died a month after valve ablation from renal failure, 
while one (12.5%) had residual valve requiring a repeat valve ablation. Post-operative complication of 
urosepsis occurred in two patients (25%).
Conclusions: Physicians should have a high index of suspicion for PUV in boys who present with 
recurrent fever or urinary tract infections. Screening for foetal anomalies during routine ante-natal 
maternal ultrasonography will improve prenatal diagnosis of this condition.
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Valve urétrale postérieure: examen rétrospectif des cas et des défis de la 
prise en charge dans un centre à faibles ressources.
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Resume
Objectif: Le diagnostic et la prise en charge des valves postérieures de l'urètre (PUV) restent un défi 
majeur dans les pays en développement. Nous avons cherché à examiner les cas de PUV gérés dans notre 
centre de santé et à mettre en évidence les défis de sa gestion.
Méthodes: Une analyse rétrospective des patients atteints de PUV pris en charge sur une période de 12 
moi. Les données obtenues à partir des dossiers médicaux des patients comprennent: démographie, 
présentation clinique, électrolytes sériques, urée et créatinine. diagnostic radiologique, prise en charge 
initiale, prise en charge chirurgicale et résultat de la prise en charge.
Résultats: Huit patients ont été pris en charge pendant la période considérée. L'âge médian était de 26 
mois. La caractéristique clinique la plus courante était la fièvre récurrente. Trois patients (37,5%) 
présentaient une insuffisance rénale nécessitant une dialyse péritonéale lors de la présentation initiale. Six 
patients (75%) ont eu la valvotomie de Mohan tandis que deux (25%) sont décédés avant l'ablation de la 
valve. Un patient (12,5%) est décédé d'un mois après l'ablation de la valvule d'une insuffisance rénale, 
tandis qu'un patient (12,5%) présentait une valvule résiduelle nécessitant une nouvelle ablation de la 
valvule. Une complication postopératoire de l'urosepsie est survenue chez deux patients (25%).
Conclusions: Les médecins doivent avoir un indice élevé de suspicion de PUV chez les garçons 
présentant une fièvre récurrente ou des infections des voies urinaires. Le dépistage des anomalies fœtales 
lors d'une échographie maternelle prénatale de routine améliorera le diagnostic prénatal de cette affection.
Mots-clés: Centre à ressources limitées, Management, Nigeria, Valve urétrale postérieure.
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INTRODUCTION
Posterior urethral valve (PUV) is the 
commonest cause of bladder outlet obstruction in 
male children (1,2). It occurs with reported 
incidence of 1 in 5,000 to 8,000 live male births 
(1,3). Despite its initial description by Morgagni 
in 1717 (3), PUV still remains a major cause of 
significant morbidity and mortality worldwide. 
Posterior urethral valve affects the development 
and function of the entire urinary tract more than 
any other urinary anomaly (4). It accounts for 20 
to 40% of end stage renal disease (ESRD) in 
children (5). Presently, in most developed 
countries, about two-thirds of PUVs are 
diagnosed prenatally based on maternal 
ultrasound (3,6). However, in most parts of 
Nigeria, late presentation continues to be the 
norm. This adds to the challenges of management 
of the condition in this environment and more 
importantly, adversely impacts the outcome of 
management of these patients (7,8).
The aim of the study was to review the 
presentation, management, outcome and 
challenges in management of cases of PUV seen 
at a health centre in South west, Nigeria. This 
clinical audit will help to improve care and 
outcome of management of patients with PUV in 
a low resource settings through identification of 
changes needed to achieve an improved quality of 
care and outcome of management of patients with 
PUV. 
METHODS AND MATERIALS  
This was a 12months retrospective 
review (June 2016 to May 2017) of all PUV cases 
seen and managed at the paediatric surgery unit of 
a health centre in South West, Nigeria.
Study settings: The study was carried out in a 
tertiary hospital which serves as a referral centre 
from health institutions in Oyo North senatorial 
district of Oyo state, South West, Nigeria. The 
paediatric surgery unit of the health institution 
has two paediatric surgeons with a well-equipped 
facilities and other supportive medical staff 
(neonatologist, paediatrician, paediatric 
anaesthetist, radiologist) to take care of 
neonatal/children emergencies and elective 
cases. 
The centre has a 22 bed paediatric ward, 
10 bed neonatal ward and 6 bed neonatal 
intensive care unit. However, the centre lacked 
adequate facilities for paediatrics urological care 
such as neonatal/paediatrics renal replacement 
therapy other than peritoneal dialysis for patients 
with renal impairment; facilities for renal 
radionuclide scan for differential analysis of renal 
function and obstruction in urinary tract; 
uroflowmeter, facilities for urodynamic studies 
and paediatric endo-urology.
In the period under review, the centre 
managed 145 paediatric surgical referrals from 
various health centres in the senatorial district. 
  
Data collection: Information were obtained from 
the patients' case files retrieved from the 
hospital's medical records department. The 
information obtained included the age at 
presentation, clinical features and duration of 
observed symptoms, prenatal maternal 
ultrasonography, period of diagnosis of 
PUV(pre-natal or post-natal diagnosis), renal 
function assessment with serum  electrolytes, 
urea and creatinine at the time of presentation, 
types of radiological diagnosis and features 
observed, initial medical treatment such as 
urethral catheterization, antimicrobial therapy 
and dialysis,  definitive surgical procedures, 
post-surgical procedure urethral drainage and 
duration of drainage; the outcome of 
management of the patients; morbidity and 
mortality rate and duration of follow up of the 
patients.
Outcome of management was assessed 
by improvement in the obstructive symptoms, 
observed urine flow pattern with estimated urine 
flow rate (normal urine flow rate ≥ 15mls/sec), 
post procedural ultrasound to check for any 
improvement in the ultrasound features of 
hydronephrosis and analysis of post procedural 
changes in serum electrolytes, urea and 
creatinine.
Estimated urine flow pattern and flow 
rate were achieved by the physician visually 
observing the patients micturating after removal 
of urethral catheter with emphasis on the pattern 
of urine flow and an estimated flow rate derived 
by dividing amount of urine voided by time 
expended in voiding. In assessing the flow rate in 
neonates and infants, initiation of micturition was 
achieved by voiding- provocation manoeuvre in 
which the lower abdomen is lightly pressed with 
examiner's thumb; success of which depends on 
the neonate having significant urine in the urinary 
bladder during the manoeuvre. The urine voided 
was collected in a cellophane bag applied to the 
penis before voiding provocation manoeuvre and 
estimated urine flow rate gotten by dividing the 
voided volume by the micturition time. 
Repeat valvotomy under general 
anaesthesia was done in any condition of failure 
of micturition with good flow rate after initial 
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valve ablation. Also, any case with suspected 
vesico-ureteric reflux (VUR) was referred to a 
health institution with more advanced facilities 
for further investigation and management.
Data analysis: Data collected were analyzed 
using the Statistical Package for the Social 
Sciences (IBM Corp. Released 2012. IBM SPSS 
Statistics for Windows, Version 21.0. Armonk, 
NY: IBM Corp). Categorical data were 
summarized as frequencies, proportions and 
rates, while continuous data were summarized 
using mean, standard deviation, median and 
range.
Ethical consideration: Ethical approval was 
obtained from the Ethical Review Committee of 
the health institution to carry out the retrospective 
review of cases of PUVs managed in the period 
under review.
RESULTS
Eight boys out of 145 paediatric surgical 
referrals had PUV and were managed in the 
period under review, accounting for 5.5% of all 
paediatric surgical referrals. The age at 
stpresentation ranged between the 1  day of life and 
11 years, with a median age of 26 months. Three 
of the patients (37.5%) presented within the first 
year of life while the remaining patients 
presented after the first year of life [Table 1]. 
The most common presenting symptom 
in the patients was recurrent fever in six (75%) 
patients followed by four (50%) who had 
straining at micturition, and three (37.5%) had 
terminal dribbling of urine [Table 2]. Other 
symptoms included abdominal distension 
(37.5%), respiratory distress (25%), facial 
puffiness (25%) and feeling of incomplete 
bladder emptying (25%). Respiratory distress 
was observed only in the neonates.
Five (62.5%) of them had a palpable 
bladder at presentation. One of the patients had an 
associated unilateral inguinoscrotal hernia and 
another had an umbilical hernia. Five (62.5%) of 
the patients had laboratory evidence of urinary 
tract infection (UTI), and four (50%) presented in 
urosepsis, all requiring initial antimicrobial 
treatment. Three (37.5%) had evidence of renal 
insufficiency requiring initial peritoneal dialysis. 
The mean pre-operative serum creatinine was 4.7 
(± 3.9) mg/dl (ref.: 0.1 to 1.2 mg/dl).
All the patients' mothers had antenatal 
ultrasound done, however, only one (12.5%) had 
a prenatal suspicion of bladder outlet obstruction 
made at 35 weeks of gestation. The remaining 
seven patients(87.5%) were diagnosed in the 
post-natal period with abdominopelvic 
ultrasonography and expressed micturating 
cystourethrogram (MCUG) with findings of 
bilateral hydronephrosis, hydroureters, 
thickened bladder wall, dilated urinary bladder; 
and the “key-hole” sign on abdomino-pelvic 
ultrasonography and irregular bladder outline 
with dilated and elongated posterior urethra on 
MUCG.
All the patients had initial bladder 
drainage with Foley's urethral catheter 
appropriate size for age. Six of these patients 
had primary valve ablation with the 
Mohan's valvotome and thereafter, continuous 
bladder drainage was done using appropriate size 
of Foley's catheter for age. Mean duration of 
catheter drainage after valvotomy was 9 ± 3 days 
(n=6). 
Five patients (83.3%) out of the 6 
patients that had valve ablation with Mohan's 
valvotome showed immediate improvement in 
their obstructive urinary symptoms with an 
estimated urine flow rate of between 16 and 
20mls/sec and improvement in the ultrasound 
features of bilateral hydronephrosis. In addition, 
five of the patients (83.3%) out of the 6 patients 
that had valve ablation with Mohan's valvotome 
had improved serum electrolytes, urea and 
creatinine after valve ablation with the Mohan's 
valvotome. The mean post-operative serum 
creatinine was 1.3 (± 0.7) mg/dl (ref.: 0.1 to 1.2 
mg/dl).
A repeat valvotomy with Mohan's 
valvotome was done in one patient (16.7%, n=6) 
on account of persistent obstructive urinary 
symptoms. Following the repeat valvotomy, 
there was improvement in the obstructive 
symptoms but recurrent UTI persisted; thus, the 
possibility of an associated vesico-ureteric reflux 
(VUR) was considered. Hence, he was referred to 
a health institution with more advanced facilities 
for further investigation and management. Only 
two (33.3%) out of the 6 patients (n=6) who had 
valvotomy, had post- valvotomy UTI. 
Three of the patients died, giving a 
mortality rate of 37.5% ; two patients died before 
valve ablation from overwhelming sepsis and 
renal failure while the third mortality was 
recorded in a patient who died a month after valve 
ablation from renal failure. 
The median follow-up period after valve 
ablation was six months, with a maximum 
follow-up period of ten months. Renal function 
has remained within normal limits in these 
patients during the follow-up period.
(75%) 
Res. J. of Health Sci. Vol 6(3), July/Sept., 2018                                                       116
PUV: Management and its challenges                                                                Ajao et al 
DISCUSSION
Posterior urethral valves (PUV) have 
thbeen described since the 18  century (3). They are 
the commonest congenital cause of bladder outlet 
obstruction in male children occurring in 1 in 
every 5,000 to 8,000 live male births (1,3,9). The 
exact aetiology of PUV is yet to be known (3). 
Posterior urethral valves result from an anterior 
insertion of the mesonephric ducts into the 
cloaca, leading to fusion of the ducts, which form 
abnormal ridges that become the valves (6). 
Progressive renal damage results from the back-
pressure effect that occur due to bladder outlet 
obstruction. Twenty-five to 40% of patients with 
PUV eventually develop renal failure (10) and 
this complication can occur in spite of valve 
ablation (11).
A total of eight cases of PUV were 
managed within a 12-month period, accounting 
for five and a half per cent of all paediatric 
surgical referrals in the centre. This rate was 
similar to the average annual number of three to 
eight PUV cases reported by Uba et al, at Jos, 
North-Central Nigeria (9) and seven by Jaja et al, 
at Port Harcourt, South-South Nigeria (5). Higher 
incidences of PUV in Nigeria have been reported, 
thus highlighting the magnitude of this problem 
in a developing country (2,13,16). 
Only three of the patients  in this 
study presented within the first year of life, a 
finding similar to reports from Ibadan  and Lagos, 
South west, Nigeria by Asinobi et al (17) and 
Ikuerowo et al (2). However, this was in contrast 
to 75.7% reported by Talabi et al from Ile-Ife, 
South-West Nigeria (12) and 68.3% by Uba et al 
from Jos, North-Central Nigeria (9). The median 
age at presentation was 26 months (2.2 years) 
with a range of one day to 11 years similar to the 
2.5 years observed in the study by Okafor et al in 
Enugu (13). 
The commonest symptoms observed was 
recurrent fever (75%) and straining at micturition 
(50%). This was similar to reports by Ikuerowo 
and Odetunde (2,7) but differs from most other 
studies where poor urinary stream was most 
common (1,9,11,13). Palpable bladder mass was 
the most common sign elicited among these 
patients (62.5%). Three (37.5%) presented with 
renal insufficiency, including one neonate, 
similar to the results from Ile-Ife and Enugu 
(7,12). In the study by Bhadoo et al, 42.8% (65 of 
152) developed chronic renal failure (CRF) and 
they found no significant difference in the 
occurrence of CRF between those presenting 
before and after the first year of life (10). 
Peritoneal dialysis was used for renal 
(37.5%) 
replacement therapy in the patients in this series, 
with satisfactory outcomes before proceeding to 
the surgical management. 
T h e  a v a i l a b i l i t y  o f  p r e n a t a l  
ultrasonographic diagnosis of this condition has 
now made it possible for early detection and 
intervention. Suspicion of PUV can be made as 
early as 18 to 20 weeks gestation by maternal 
ultrasound scan showing oligohydramnios, 
bilateral hydroureteronephrosis and a distended 
bladder (3,6). Fortunately, ultrasonography is 
readily available in most developing countries. 
However, prenatal diagnosis of PUV still remains 
low in Nigeria (2,12-14). In the present study, 
despite all the mothers having at least one 
antenatal ultrasound examination, only one 
(12.5%) had prenatal suspicion of PUV, and this 
was only made at 35 weeks gestation. 
The mode of valve ablation in this study 
was valve ablation with Mohan's valvotome 
which has been shown to be effective method for 
valve ablation with comparable results to that 
achieved through endoscopy (16,18,19). This has 
proved to be valuable in our centre where facility 
for endoscopic ablation is unavailable. No 
mortality directly linked to the procedure was 
observed. 
In this study, mortality rate was 37.5% 
which was higher than that observed in the other 
series earlier cited, of which 20% was the highest 
reported in Port Harcourt by Jaja et al (5). The 
higher mortality rate observed in this series may 
have been due to the small sample size and the 
delayed presentation in our patients.
Challenges in Management
Despite ultrasonography being readily 
available in Nigeria and antenatal maternal 
ultrasonography routinely done in the antenatal 
period as observed in this study, yet prenatal 
diagnosis of PUV is almost non-existent. 
Apparently, in most of the antenatal maternal 
ultrasound scan done emphasis was on the 
number of foetus, presentation and viability of 
the gestation with no prenatal screening for 
anomalies in the foetus. 
Prenatal diagnosis of PUV allow for 
early intervention which may require in-utero 
ablation of the valve; however, such foetal 
intervention remain controversial. In addition, 
identification of patients that will benefit from it 
remain elusive; however, early delivery is still a 
viable option in foetuses with significant renal 
impairment (3,15). In developing countries, the 
opportunity to take such decision is often denied 
when prenatal diagnosis are not made.
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In the absence of prenatal diagnosis, post-natal 
diagnosis and late presentation is the norm. The 
median age at presentation in this study was 26 
months (2.2years). In respect to the late 
presentations, it is not unexpected to find 
substantial number of the patients with renal 
insufficiency (37.5%) at presentation that 
required peritoneal dialysis before the valve 
ablation. 
Mohan's valvotome have been found to 
be useful in valve ablation with comparable result 
with endoscopic valve ablation (16,18,19); 
Albeit, it may be associated with inadequacy of 
valve ablation (20) as the procedure is done 
blindly unlike endoscopic valve ablation which is 
usually performed under direct vision. In this 
study, there was failure of satisfactory ablation of 
valve in one of the patient which necessitated a 
repeat procedure. Although, no other morbidity 
or mortality was directly linked to the procedure; 
however, it should be emphasized that 
appropriate size of valvotome should be used on 
the child's urethra as valvotome larger than the 
urethra may result in urethral stricture (21).
Adequacy of valve ablation should result 
in improved urinary stream, objectively assessed 
by urinary flow rate. Urinary flow rate in an older 
child is usually assessed by uroflowmetry while 
in neonate, ultrasound flow probe can be used to 
assess urinary flow pattern as demonstrated by 
Olsen et al, in which an ultrasound flow probe 
connected to a flowmeter was mounted on the 
penis of the newborn to assess the flow curve 
configuration, maximum flow rate and voided 
volume (22). Such objective assessment of 
urinary flow rate was a challenge in our setting as 
visual assessment of the urine stream and 
subjective estimated flow rate were used to assess 
the patients' urinary stream in this study which is 
less than the ideal, due to non-availability of 
uroflowmeter and ultrasound flow probes in our 
institution. 
CONCLUSION
A posterior urethral valve is a not an 
uncommon condition affecting young boys in our 
environment. It should be ruled out in boys with 
repeated presentation of fever or recurrent 
urinary tract infection. Parents may not be aware 
of obstructive urinary symptoms in their 
children; hence, physicians must have a high 
index of suspicion in diagnosing the condition in 
the post-natal period. Screening for foetal 
anomalies during routine antenatal maternal 
ultrasonography will ensure prenatal diagnosis of 
posterior urethral valve thereby reducing the 
number of patients presenting late in our 
environment. Also, endoscopic valve ablation 
under direct vision may prevent inadequacy of 
valve ablation which may occur in blind valve 
ablation such as Mohan's valvotomy.
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Table 1: Frequency distribution of age at presentation and mortality 
 
Age at presentation n (%) Mortality (%) 
< 1year 3(37.5)       2(25.0) 
>1year 5(62.5)       1(12.5) 








Table 2: Distribution of clinical features at presentation 
 
Clinical features Frequency (%) 
(n=8) 
Recurrent fever 6 (75) 
Palpable bladder 5 (62.5) 
Urinary tract infection 5 (62.5) 
Straining at micturition 4 (50) 
Poor urine stream 4 (50) 
Urosepsis  4 (50) 
Abdominal distension 3 (37.5) 
Terminal dribbling 3 (37.5) 
Renal failure 3 (37.5) 
Facial swelling 2 (25) 
Incomplete bladder emptying 2 (25) 
Respiratory distress 2 (25) 
Prenatal diagnosis 1 (12.5) 
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